In Vitro ADME and Preclinical Pharmacokinetics of Ulotaront, a TAAR1/5-HT1A Receptor Agonist for the Treatment of Schizophrenia
用户yq6YsVZ7xRog
3小时前
7
10
已完结
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-08-13 17:21:26 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1007/s11095-022-03267-1
文献链接: https://link.springer.com/10.1007/s11095-022-03267-1
其他信息:
出版社: Springer Science and Business Media LLC
作者: Guangqing Xiao; Yu-Luan Chen; Nina Dedic; Linghong Xie; Kenneth S. Koblan; Gerald R. Galluppi
全文下载地址: https://link.springer.com/content/pdf/10.1007/s11095-022-03267-1.pdf
